The additional finding of the strong similarity shared with two clinically relevant tumor antigens suggests that these HSP sequences may function as shared tumor antigens capable of eliciting a potent immune response, similar to that triggered by SAg exotoxins. The gene discussed is HSP90B2P; the disease is neoplasm.